Drug Shortage Report for MYLAN-DIVALPROEX

Last updated on 2022-07-06 History
Report ID 160866
Drug Identification Number 02458934
Brand name MYLAN-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 250MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100BT, 500BT
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-06-22
Actual start date 2022-06-20
Estimated end date 2022-06-30
Actual end date 2022-06-30
Shortage status Resolved
Updated date 2022-07-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-07-06 French Compare
v8 2022-07-06 English Compare
v7 2022-06-29 French Compare
v6 2022-06-29 English Compare
v5 2022-06-23 English Compare
v4 2022-05-31 French Compare
v3 2022-05-31 English Compare
v2 2022-05-18 French Compare
v1 2022-05-18 English Compare

Showing 1 to 9 of 9